The Congressional Budget Office is under new leadership, and the agency made it clear Tuesday that a different type of economic analysis will be used to study the effects of federal spending policies, particularly those in healthcare. That could affect projections regarding the ACA.
Why is the nation's capital suddenly obsessed with biomedical innovation? And why is the fruit of that obsession, the 21st Century Cures Act, moving like a greased pig through the usually deadlocked Congress—even as some experts warn it could undermine the FDA's ability to protect the public...
The Senate on Tuesday adopted a Republican budget that paves the way for an assault on President Barack Obama's signature healthcare law this summer and a partisan showdown over spending bills this fall.
Maui's only acute care hospital and two other state-owned medical facilities could be privatized under a bill given final approval by state lawmakers.
Proposed legislation “modernizing” the Food and Drug Administration's approach to approving breakthrough drugs and devices would undermine the agency's ability to protect the American public from unproven and possibly unsafe new products.
A new draft of House legislation that creates significant new regulatory leeway for drug and device companies now includes more funding for the National Institutes of Health. The revised draft represents a compromise with Democrats who withdrew support for the initial bill.
There are signs of a partisan thaw in Congress that is allowing movement on healthcare legislation in the wake of the recent Medicare physician-payment overhaul. And a sharp uptick in lobbying spending by major healthcare industry groups suggests stakeholders see at least a temporary break in the...
House and Senate Republicans are likely to agree on a budget that abolishes the healthcare reform law. But the real discussion about 2016 spending will come as another government shutdown looms toward the end of September.
Likely Republican presidential candidate Jeb Bush wants to require everyone to fill out an advance directive governing their end-of-life care before they can receive Medicare benefits. His proposal is both ironic and politically audacious.
Providers are raising alarms about potential cuts to Medicare that would bankroll benefits for workers hurt by future free-trade agreements.
Physician assistants and nurse practitioners cheered passage of the bill that killed Medicare's sustainable-growth rate formula. But a failed attempt by Yale University to expand its PA program with an online option reflects the difficulty of trying to rapidly grow the healthcare workforce.
The healthcare industry is celebrating the demise of Medicare's sustainable growth-rate formula for paying physicians. At least a few skeptics are already questioning the new framework, which is intended to push doctors to embrace value-based pay.